- Home
- IMRX vs ASLE Comparison
IMRX vs ASLE Comparison
Compare IMRX & ASLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IMRX | ASLE |
|---|---|---|
| Founded | 2008 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 322.8M | 336.9M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | IMRX | ASLE |
|---|---|---|
| Price | $5.32 | $6.49 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $17.20 | $7.00 |
| AVG Volume (30 Days) | ★ 687.8K | 153.7K |
| Earning Date | 01-01-0001 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.75 | ★ 173.33 |
| EPS | N/A | ★ 0.06 |
| Revenue | N/A | ★ $345,066,000.00 |
| Revenue This Year | N/A | $24.23 |
| Revenue Next Year | N/A | $23.67 |
| P/E Ratio | ★ N/A | $122.08 |
| Revenue Growth | N/A | ★ 3.16 |
| 52 Week Low | $1.10 | $5.56 |
| 52 Week High | $10.08 | $9.08 |
Technical Indicators
Market Signals| Indicator | IMRX | ASLE |
|---|---|---|
| Relative Strength Index (RSI) | 54.60 | 25.09 |
| Support Level | $3.93 | $5.71 |
| Resistance Level | $5.36 | $6.56 |
| Average True Range (ATR) | 0.28 | 0.24 |
| MACD | 0.04 | -0.09 |
| Stochastic Oscillator | 84.82 | 5.90 |
Price Performance
Historical ComparisonAbout IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About ASLE AerSale Corporation
AerSale Corp is an integrated, diversified leader in aviation aftermarket products and services. It specializes in the sale, lease, and exchange of used aircraft, engines, and components, in addition to providing a broad range of maintenance, repair, and overhaul, and engineering services for commercial aircraft and components. The company operating segment includes Asset Management Solutions and TechOps. It generates maximum revenue from the Asset Management Solutions segment.